Skip to main content
. 2021 Jan 20;16(1):e0245672. doi: 10.1371/journal.pone.0245672

Table 1. Epidemiological and clinical characteristics of group II participants (HCPs who experienced COVID-19) (n = 77).

Variables Number (%)
Epidemiological characteristics
 Age (years) Mean ± SD (39.09±10.43)
 Sex
  Male 42 (54.5)
  Female 35 (45.5)
 Timing of infection
  On duty 75 (97.4)
  Not on duty 2 (2.6)
 Source of SARS-CoV-2 infection
  From a COVID-19 household contact 4 (5.2)
  From a COVID-19 patient at work 30 (39.0)
  From an infected colleague (HCP) 17 (22.1)
  Uncertain 26 (33.8)
 Clinical status of source of infection
  Asymptomatic 29 (37.7)
  Symptomatic 48 (62.3)
 Site of exposure to COVID-19 patients
  Cleaning services 5 (6.5)
  Emergency 5 (6.5)
  Inpatient ward 5 (6.5)
  Intensive care Unit 15 (19.5)
  Laboratory 5 (6.5)
  Outpatient area 4 (5.2)
  Operating room 5 (6.5)
  Pharmacy 2 (2.6)
  Radiology/imaging 2 (2.6)
  Reception area 2 (2.6)
  Accommodation 1 (1.3)
  Unknown 23 (29.9)
  Others 4 (5.2)
Clinical characteristics
 COVID-19 symptoms
  Asymptomatic 7 (9.1)
  Symptomatic 70 (90.9)
 COVID-19 severity (n = 70)
  Mild 41 (58.6)
  Moderate 21 (30.0)
  Severe 8 (11.4)
 Place of isolation
  At home 58 (75.3)
  Admitted to hospital 19 (24.7)

Data are presented as mean ± SD for continuous variables and as number (percentage) for categorical variables.

COVID-19; Corona Virus Disease 2019, HCP; Healthcare Providers, SARS-CoV-2; Severe Acute Respiratory Syndrome Coronavirus 2.